Aggressive Behavior Linked to Corticotropin-Reactive Autoantibodies

Biological Psychiatry

Volumn 60, Issue 8, 2006, Pages 799-802

  Fetissov, Sergueï O ^a   Hallman, Jarmila ^b   Nilsson, Ida ^a   Lefvert, Ann Kari ^a   Oreland, Lars ^b   Hökfelt, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; conduct disorder; neuroendocrinology; neuropeptides; neuropsychoimmunology; stress

Indexed keywords

ALPHA INTERMEDIN; AUTOANTIBODY; CORTICOTROPIN; IMMUNOGLOBULIN M; NEUROHORMONE; OXYTOCIN; VASOPRESSIN;

ADULT; AGGRESSION; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; COMPARATIVE STUDY; CONDUCT DISORDER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; PRISONER; STRESS; VIOLENCE;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGGRESSION; ALPHA-MSH; ANTISOCIAL PERSONALITY DISORDER; AUTOANTIBODIES; CONDUCT DISORDER; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MIDDLE AGED; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; OXYTOCIN; PRISONERS; PSYCHIATRIC STATUS RATING SCALES; STRESS, PSYCHOLOGICAL; VASOPRESSINS; VIOLENCE;

EID: 33749513199     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.081     Document Type: Article

References (47)

1. Anderberg U.M., and Uvnäs-Moberg K. Plasma oxytocin levels in female fibromyalgia syndrome patients. Z Rheumatol 59 (2000) 373-379
2. Bale T.L., Davis A.M., Auger A.P., Dorsa D.M., and McCarthy M.M. CNS region-specific oxytocin receptor expression: Importance in regulation of anxiety and sex behavior. J Neurosci 21 (2001) 2546-2552
3. Bosch O.J., Meddle S.L., Beiderbeck D.I., Douglas A.J., and Neumann I.D. Brain oxytocin correlates with maternal aggression: link to anxiety. J Neurosci 25 (2005) 6807-6815
4. Burgdorf J., and Panksepp J. The neurobiology of positive emotions. Neurosci Biobehav Rev 30 (2006) 173-187
5. Choleris E., Gustafsson J.A., Korach K.S., Muglia L.J., Pfaff D.W., and Ogawa S. An estrogen-dependent four-gene micronet regulating social recognition: A study with oxytocin and estrogen receptor-alpha and -beta knockout mice. Proc Natl Acad Sci U S A 100 (2003) 6192-6197
6. Chrousos G.P., and Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267 (1992) 1244-1252
7. Coutinho A., Kazatchkine M.D., and Avrameas S. Natural autoantibodies. Curr Opin Immunol 7 (1995) 812-818
8. Dallman M.F. Fast glucocorticoid actions on brain: Back to the future. Frontiers in Neuroendocrinology 26 (2005) 103-108
9. de Wied D., Diamant M., and Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 14 (1993) 251-302
10. Demitrack M.A., Kalogeras K.T., Altemus M., Pigott T.A., Listwak S.J., and Gold P.W. Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjects. J Clin Endocrinol Metab 74 (1992) 1277-1283
11. Ebner K., Wotjak C.T., Landgraf R., and Engelmann M. Neuroendocrine and behavioral response to social confrontation: Residents versus intruders, active versus passive coping styles. Horm Behav 47 (2005) 14-21
12. Ferguson J.N., Young L.J., Hearn E.F., Matzuk M.M., Insel T.R., and Winslow J.T. Social amnesia in mice lacking the oxytocin gene. Nat Genet 25 (2000) 284-288
13. Fetissov S.O. Autoimmune component in anorexia and bulimia nervosa. In: Fatemi S.H. (Ed). Neuropsychiatric Disorders and Infection (2004), Taylor and Francis, London 296
14. Fetissov S.O., Hallman J., Oreland L., af Klinteberg B., Grenbäck E., Hulting A.L., et al. Autoantibodies against α-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc Natl Acad Sci U S A 99 (2002) 17155-17160
15. Fetissov S.O., Harro J., Jaanisk M., Järv A., Podar I., Allik J., et al. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci U S A 102 (2005) 14865-14870
16. Griebel G., Simiand J., Serradeil-Le Gal C., Wagnon J., Pascal M., Scatton B., et al. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci U S A 99 (2002) 6370-6375
17. Guilbert B., Dighiero G., and Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol 128 (1982) 2779-2787
18. Halasz J., Liposits Z., Kruk M.R., and Haller J. Neural background of glucocorticoid dysfunction-induced abnormal aggression in rats: Involvement of fear- and stress-related structures. Eur J Neurosci 15 (2002) 561-569
19. Haller J., Mikics E., Halasz J., and Toth M. Mechanisms differentiating normal from abnormal aggression: Glucocorticoids and serotonin. Eur J Pharmacol 526 (2005) 89-100
20. Haller J., Toth M., and Halasz J. The activation of raphe serotonergic neurons in normal and hypoarousal-driven aggression: A double labeling study in rats. Behav Brain Res 161 (2005) 88-94
21. Hayakawa K., Asano M., Shinton S.A., Gui M., Allman D., Stewart C.L., et al. Positive selection of natural autoreactive B cells. Science 285 (1999) 113-116
22. Hill J. Biological, psychological and social processes in the conduct disorders. J Child Psychol Psychiatry 43 (2002) 133-164
23. Huber D., Veinante P., and Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308 (2005) 245-248
24. Kastin A.J., and Pan W. Peptide transport across the blood-brain barrier. Prog Drug Res 61 (2003) 79-100
25. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., et al. Cognition and immunity: Antibody impairs memory. Immunity 21 (2004) 179-188
26. Kratzer L., and Hodgins S. Adult outcomes of child conduct problems: A cohort study. J Abnorm Child Psychol 25 (1997) 65-81
27. Landgraf R., and Neumann I.D. Vasopressin and oxytocin release within the brain: A dynamic concept of multiple and variable modes of neuropeptide communication. Frontiers Neuroendocrinol 25 (2004) 150-176
28. Lefkowitz R.J., Roth J., Pricer W., and Pastan I. ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase. Proc Natl Acad Sci U S A 65 (1970) 745-752
29. Legros J.J. Inhibitory effect of oxytocin on corticotrope function in humans: Are vasopressin and oxytocin ying-yang neurohormones?. Psychoneuroendocrinology 26 (2001) 649-655
30. Lim M.M., Wang Z., Olazabal D.E., Ren X., Terwilliger E.F., and Young L.J. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature 429 (2004) 754-757
31. Lindberg E., Adlerberth I., and Wold A.E. Antibiotic resistance in Staphylococcus aureus colonising the intestines of Swedish infants. Clin Microbiol Infect 10 (2004) 890-894
32. Nelson R.J., and Chiavegatto S. Molecular basis of aggression. Trends Neurosci 24 (2001) 713-719
33. Neumann I.D. Involvement of the brain oxytocin system in stress coping: Interactions with the hypothalamo-pituitary-adrenal axis. Prog Brain Res 139 (2002) 147-162
34. Oldstone M.B. Molecular mimicry and immune-mediated diseases. Faseb J 12 (1998) 1255-1265
35. O'Mahony R., Vaira D., Holton J., and Basset C. Helicobacter pylori: Current status and future prospects. Sci Prog 87 (2004) 269-296
36. Pan W., Solomon B., Maness L.M., and Kastin A.J. Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide. Exp Biol Med (Maywood) 227 (2002) 609-615
37. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Pinto E., Reggers J., et al. AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocrinology 30 (2005) 839-845
38. Sewards T.V., and Sewards M.A. Fear and power-dominance motivation: Proposed contributions of peptide hormones present in cerebrospinal fluid and plasma. Neurosci Biobehav Rev 27 (2003) 247-267
39. Stoehr J.D., Cramer C.P., and North W.G. Oxytocin and vasopressin hexapeptide fragments have opposing influences on conditioned freezing behavior. Psychoneuroendocrinology 17 (1992) 267-271
40. Swaab D.F. Neuropeptides in hypothalamic neuronal disorders. Int Rev Cytol 240 (2004) 305-375
41. Swanson L.W. Anatomy of the soul as reflected in the cerebral hemispheres: Neural circuits underlying voluntary control of basic motivated behaviors. J Comp Neurol 493 (2005) 122-131
42. Telegdy G., and Vermes I. Effect of adrenocortical hormones on activity of the serotoninergic system in limbic structures in rats. Neuroendocrinology 18 (1975) 16-26
43. van Goozen S.H., Matthys W., Cohen-Kettenis P.T., Gispen-de Wied C., Wiegant V.M., and van Engeland H. Salivary cortisol and cardiovascular activity during stress in oppositional-defiant disorder boys and normal controls. Biol Psychiatry 43 (1998) 531-539
44. van Londen L., Kerkhof G.A., van den Berg F., Goekoop J.G., Zwinderman K.H., Frankhuijzen-Sierevogel A.C., et al. Plasma arginine vasopressin and motor activity in major depression. Biol Psychiatry 43 (1998) 196-204
45. Vanyukov M.M., Moss H.B., Plail J.A., Blackson T., Mezzich A.C., and Tarter R.E. Antisocial symptoms in preadolescent boys and in their parents: associations with cortisol. Psychiatry Res 46 (1993) 9-17
46. Virkkunen M. Urinary free cortisol secretion in habitually violent offenders. Acta Psychiatr Scand 72 (1985) 40-44
47. Watts A.G. Glucocorticoid regulation of peptide genes in neuroendocrine CRH neurons: A complexity beyond negative feedback. Frontiers Neuroendocrinol 26 (2005) 109-130